Sernova Biotherapeutics's quarterly market cap
declined
from Jul. 2024 (€54.71 Mil) to Oct. 2024 (€51.66 Mil) and
declined
from Oct. 2024 (€51.66 Mil) to Jan. 2025 (€44.77 Mil).
Sernova Biotherapeutics's annual market cap
declined
from Oct. 2022 (€181.85 Mil) to Oct. 2023 (€156.67 Mil) and
declined
from Oct. 2023 (€156.67 Mil) to Oct. 2024 (€51.66 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sernova Biotherapeutics's Enterprise Value for Today is €32.44 Mil.
Sernova Biotherapeutics Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sernova Biotherapeutics's Market Cap
For the Biotechnology subindustry, Sernova Biotherapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sernova Biotherapeutics's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where Sernova Biotherapeutics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sernova Biotherapeutics's Market Cap for the fiscal year that ended in Oct. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sernova Biotherapeutics (FRA:PSH0) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sernova Biotherapeutics Market Cap Related Terms
Thank you for viewing the detailed overview of Sernova Biotherapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:PSH0 has been successfully added to your 